Baricitinib tablets bulk supplier for pharma manufacturers

Baricitinib Tablets 2 mg, 4 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 2 mg, 4 mg

Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)

Category: Arthritis

Baricitinib inhibits Janus kinase (JAK) enzymes, disrupting cytokine signaling involved in inflammation. It effectively reduces symptoms and slows disease progression in rheumatoid arthritis. Benefits include rapid symptom relief, improved joint function, and enhanced quality of life, with convenient oral dosing and a well-established safety profile when monitored properly.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Baricitinib Tablets? List it or send an offer →

Product Description:

Baricitinib 2 mg and 4 mg tablets (reference brand Olumiant, Eli Lilly) are used for moderate to severe rheumatoid arthritis in adults who have not responded well to, or cannot take, other disease-modifying drugs, and for severe alopecia areata and, in the EU, atopic dermatitis and juvenile idiopathic arthritis. Baricitinib is a JAK1 and JAK2 inhibitor taken once daily. For Indian manufacturers, licensing history and the documents to request, see our main baricitinib page, or send us an RFQ.

Baricitinib Tablets — third party manufacturing & bulk supply

Baricitinib Tablets 2 mg, 4 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Baricitinib Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Baricitinib Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Baricitinib Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Baricitinib tablets is listed as Tablets in 2 mg, 4 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Baricitinib tablets is referenced against Olumiant®(EU & US- Emergency Use Authorization (EUA). Reference brands are shown for identification only and remain the property of their respective trademark owners.